期刊文献+

心脏核磁共振在心肌淀粉样变中的诊断价值 被引量:12

Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis
原文传递
导出
摘要 目的 研究心内膜心肌活检(EMB)确诊心肌淀粉样变性(CA)患者的临床和心脏核磁共振(CMR)特点,明确CMR在CA中的诊断价值。方法回顾性分析2006年9月至2010年12月期间EMB确诊CA并行CMR检查患者的临床表现、心电图、心脏超声及CMR结果。结果共18例患者通过EMB确诊为CA,其中5例进行了CMR检查。5例患者均有心力衰竭的临床表现以及心电图改变,心脏超声示左心室向心性肥厚,心肌回声增强、颗粒样回声,左心房扩大,限制性舒张功能不全。CMR主要表现为左心室壁增厚,室间隔增厚明显,双房均增大,心室收缩功能正常或减低,舒张功能均不同程度受限,部分伴有心包及胸腔积液,延迟钆显像(LGE)呈不同程度的延迟强化,位于左心室心内膜下或心肌弥漫性延迟强化,部分患者强化可为线样、颗粒样或斑片状。随病程延长,心肌LGE程度及范围有更严重的趋势,与心电图改变一致。结论CMR有助于CA诊断及病情判断,为CA重要的无创检查方法之一。临床怀疑CA患者可早期进行CMR检查,特别是在没有开展EMB检查的医院。 Objective To observe the clinical features and cardiac magnetic resonance imaging (CMR) characteristics of patients with endomyocardial biopsy(EMB)-proven cardiac amyloidosis (CA). Methods EMB proven CA patients underwent CMR examination from September 2006 to December 2010 were included. The findings of clinical manifestation, electrocardiogram, echocardiography and CMR were analyzed. Results Among the 18 patients with EMB verified CA, 5 patients underwent CMR. All 5 patients had heart failure symptoms and electrocardiogram was abnormal. Echzcardiogram showed concentric left ventricular hypertrophy, granular appearance of the myocardium, left atrial enlargement and moderate to severe left ventricular diastolic dysfunction. CMR revealed increased thickness of the left ventricular wall (especially at the inter-ventricular septum), enlarged bilateral auricle, restricted left ventricular filling with normal or mild to moderate reduced systolic function. Pleura1 and pericardial effusions were observed in 2 patients. Abnormal late gadolinium enhancement (LGE) was detected in all 5 patients. CMR revealed different patterns of LGE. Left ventricular global subendocardial delayed gadolinium enhancement or transmural delayed gadolinium enhancement were found, and patients also showed line-, granular- or patchy- like enhancement. The degree and range of LGE paralleled the disease course and were consistent with electrocardiogram changes. Conclusions As a noninvasive diagnostic tool, CMR is valuable in the diagnosis of CA. For patients with clinical suspicion of CA, CMR could be a helpful diagnostic tool, especially in the hospitals where EMB is not available.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2011年第10期915-919,共5页 Chinese Journal of Cardiology
关键词 心肌疾病 淀粉样变性 磁共振成像 活组织检查 Cardiomyopathies Amyloidosis Magnetic resonance imaging Biopsy
  • 相关文献

参考文献20

  • 1Rapezzi C,Merlini G,Quarta CC,et al.Systemic cardiac amyloidoses:disease profiles and clinical courses of the 3 main types.Circulation,2009,120:1203-1212.
  • 2Maceira AM,Joshi J,Prasad SK,et al.Cardiovascular magnetic resonance in cardiac amyloidosis.Circulation,2005,111:186-193.
  • 3Vogelsberg H,Malhrholdt H,Deluigi CC,et al.Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis:noninvasive imaging compared to endomyocardial biopsy.J Am Coll Cardiol,2008,51:1022-1030.
  • 4Austin BA,Tang WH,Rodriguez ER,et al.Delayed hyperenhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.JACC Cardiovasc Imaging,2009,2:1369-1377.
  • 5Ruberg FL,Appelbaum E,Davidoff R,et al.Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis.Am J Cardiol,2009,103:544-549.
  • 6Syed IS,Glockner JF,Feng D,et al.Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.JACC Cardiovasc Imaging,2010,3:155-164.
  • 7程中伟,田庄,康琳,陈太波,方理刚,程康安,曾勇,方全.心脏淀粉样变患者的心电图和心脏超声特点[J].中华心血管病杂志,2010,38(7):606-609. 被引量:22
  • 8程中伟,方全.心肌淀粉样变的无创诊断方法与临床分型研究进展[J].中华心血管病杂志,2011,39(2):185-187. 被引量:10
  • 9Sanchorawala V,Wright DG,Seldin DC,et al.An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.Bone Marrow Transplant,2001,28:637-642.
  • 10Cheng Z,Kang L,Tian Z,et al.Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis.Ann Noninvasive Electrocardiol,2011,16:25-29.

二级参考文献78

  • 1孟磊,丁文惠,史力斌,龚艳君,刘兆平.免疫球蛋白轻链型淀粉样变性病心脏受累的临床特征及预后[J].中华心血管病杂志,2007,35(4):340-343. 被引量:10
  • 2HigginsCB,DeRoosA.心血管MRI和MRA.郑州:河南科学技术出版社,2008:338-339.
  • 3Picano E,Pinamonti B,Ferdeghini EM,et al.Two-dimensional echocardiography in myocardial amyloidosis.Echocaidiograpfay,1991,8:253-259.
  • 4Austin BA,Duffy B,Tan C,et al.Comparison of functional status,electrocardiographic,and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis.Am J Cardiol,2009,103:1429-1433.
  • 5Falk RH.Diagnosis and management of the cardiac amyloidoses.Circulation,2005,112:2047-2060.
  • 6Gardin JM,Adams DB,Douglas PS,et al.American Society of Echocardiography.Recommendations for a standardized report for adult transthoracic echocardiography:a report from the American Society of Echocardiography' s Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report.J Am Soc Echocardiogr,2002,15:275-290.
  • 7Murtagh B,Hammill SC,Gertz MA,et al.Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.Am J Cardiol,2005,95:535-537.
  • 8Rapezzi C,Merlini C,Quarta CC,et al.Systemic cardiac amyloidoses:disease profiles and clinical courses of the 3 main types.Circulation,2009,120:1203-1212.
  • 9Rahman JE,Helou EF,Gelzer-Bell R,et al.Noninvasive diagnosis of biopsy-proven cardiac amyloidosis.J Am Coll Cardiol,2004,43:410-415.
  • 10Carroll JD,Gaasch WH,Me Adam KP.Amyloid cardiomyopathy:characterization by a distinctive voltage/mass relation.Am J Cardiol,1982,49:9-13.

共引文献35

同被引文献197

  • 1马爱群,吴格如.心脏淀粉样变性诊断与治疗(附病例介绍与分析)[J].中华心血管病杂志,2006,34(12):1150-1152. 被引量:18
  • 2张青,王振常,赵波,鲜军舫,田其昌,张华,吴超,李岩,罗福燕,牛延涛,史旭波.心脏磁共振延迟强化成像定量评价心肌梗死的研究[J].临床荟萃,2007,22(10):696-699. 被引量:4
  • 3Selvanayagam JB,Hawkins PN,Paul B. Evaluation and management of the cardiac amyloidosis[J].{H}Journal of the America College of Cardiology,2007,(22):2101-2110.
  • 4García-Pavía P,Tomé-Esteban MT,Rapezzi C. Amyloidosis. Also a heart disease[J].{H}Revista Espanola de Cardiologia,2011,(09):797-808.
  • 5Guidelines Working Group of UK Myeloma Forum,British Commitee for Standards in Haematology,British Society for Haematology. Guidelines on the diagnosis and management of AL amyloidosis[J].{H}British Journal of Haematology,2004,(06):681-700.
  • 6Murtagh B,Hammill SC,Gertz MA. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement[J].{H}American Journal of Cardiology,2005,(04):535-537.
  • 7Rahman JE,Helou EF,Gelzer-Bell R. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis[J].{H}Journal of the America College of Cardiology,2004,(03):410-415.
  • 8Vogelsberg H,Mahrholdt H,Deluigi CC. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis:noninvasive imaging compared to endomyocardial biopsy[J].{H}Journal of the America College of Cardiology,2008,(10):1022-1030.
  • 9Cheng Z,Kang L,Tian Z. Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis[J].{H}Ann Non-invasive Electrocardiography,2011,(01):25-29.
  • 10Ruberg FL,Appelbaum E,Davidoff R. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis[J].{H}American Journal of Cardiology,2009,(04):544-549.

引证文献12

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部